| Inlive (enterovirus type 71 vaccine（Vero Cell), inactivated) / Sinovac |
NCT03278132: Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine |
|
|
| Completed | 4 | 120 | RoW | EV71 vaccine | Sinovac Biotech Co., Ltd, Zhejiang Provincial Center for Disease Control and Prevention, Shangyu District Center for Disease Control and Prevention | Hand, Foot and Mouth Disease | 09/17 | 09/17 | | |
NCT03274102: Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines |
|
|
| Completed | 4 | 780 | RoW | Concomitant administration of EV71 vaccine with EPI vaccines, Single injection of EPI vaccine, EV71 Vaccine only | Sinovac Biotech Co., Ltd, Guangdong Center for Disease Prevention and Control | Hand, Foot and Mouth Disease | 11/17 | 11/17 | | |
NCT03873740: Immunogenicity and Safety of Two Different Commercial EV71 Vaccines |
|
|
| Completed | 4 | 300 | RoW | EV71 inactived vaccine（Vero cells）, EV71 inactived vaccine（Human diploid cells） | Sinovac Biotech Co., Ltd, Shandong Province Centers for Disease Control and Prevention | Hand, Foot and Mouth Disease | 01/19 | 01/19 | | |
NCT04111432: Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines |
|
|
| Completed | 4 | 372 | RoW | Concomitant administration of EV71vaccine with EPI vaccines, Single injection of EPI vaccine, EV71 Vaccine only | Sinovac Biotech Co., Ltd, Shaanxi Provincial Center for Disease Control and Prevention | Hand, Foot and Mouth Disease | 11/19 | 03/20 | | |
| Completed | 4 | 15500 | RoW | 5000 volunteers (6-35 months)-EV71 vaccine | Sinovac Biotech Co., Ltd | Hand, Foot and Mouth Disease | 06/20 | 10/20 | | |
NCT05107557: Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) |
|
|
| Completed | 4 | 520 | RoW | Experimental Group, Combined immunization group | Sinovac Biotech Co., Ltd | COVID-19 | 12/21 | 07/22 | | |
PRO-nCOV-4002, NCT04993365: Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) |
|
|
| Completed | 4 | 520 | RoW | Experimental Group, Combined immunization group, Control Group, Non-combined immunization group | Sinovac Research and Development Co., Ltd. | COVID-19 | 07/22 | 07/22 | | |
NCT05397587: An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) |
|
|
| Not yet recruiting | 4 | 474 | RoW | Experimental Vaccine, Enterovirus Type 71 Vaccine（Vero Cell）, Inactivated, Control Vaccine, Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell） | Sinovac Biotech Co., Ltd | Hand, Foot and Mouth Disease | 07/25 | 10/25 | | |
